These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 319753)

  • 1. Cefoxitin activity against multiply antibiotic-resistance Klebsiella pneumoniae in vitro.
    Jackson RT; Thomas FE; Alford RH
    Antimicrob Agents Chemother; 1977 Jan; 11(1):84-7. PubMed ID: 319753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium clavulanate potentiation of cephalosporin activity against clinical isolates of cephalothin-resistant Klebsiella pneumoniae.
    Jackson RT; Harris LF; Alford RH
    Antimicrob Agents Chemother; 1978 Jul; 14(1):118-25. PubMed ID: 356723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro susceptibility of cephalothin-resistant Enterobacteriaceae to cefoxitin and BL-S786.
    Meyer RD
    J Antibiot (Tokyo); 1977 Apr; 30(4):326-9. PubMed ID: 324961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Microbiological evaluation of cefoxitin, a new beta-lactamase resistant cephamycin antibiotic, compared to cephalothin, cephaloridine and cefazolin].
    Schassan HH; Bentfeld G
    Fortschr Med; 1978 Aug; 96(30):1510-7. PubMed ID: 669547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of resistance in Staphylococcus aureus and Klebsiella pneumoniae by exposure to cephalothin and cefoxitin.
    Hoeprich PD; Huston AC
    J Infect Dis; 1976 Jun; 133(6):681-5. PubMed ID: 778303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro evaluation of cefoxitin and cefamandole.
    Adams HG; Stilwell GA; Turck M
    Antimicrob Agents Chemother; 1976 Jun; 9(6):1019-24. PubMed ID: 820241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro studies of cefamandole.
    Bodey GP; Weaver S
    Antimicrob Agents Chemother; 1976 Mar; 9(3):452-7. PubMed ID: 769679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of cephalothin-resistant gram-negative bacilli to piperacillin, cefuroxime, and other selected antibiotics.
    George WL; Lewis RP; Meyer RD
    Antimicrob Agents Chemother; 1978 Mar; 13(3):484-9. PubMed ID: 122524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefuroxime, cefamandole, cefoxitin, and cephalothin in vitro susceptibility tests: reassessment of the "class representative" concept, confirmation of disk interpretive criteria, and proposed quality control guidelines.
    Barry AL; Jones RN; Thornsberry C
    Am J Clin Pathol; 1983 Aug; 80(2):182-9. PubMed ID: 6881092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro antibacterial activity of a new 1-oxa cephalosporin compound.
    Downs JT; Andriole VT
    Yale J Biol Med; 1980; 53(2):149-59. PubMed ID: 6446810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro comparison of cefoxitin, cefamandole, cephalexin, and cephalothin.
    Eickhoff TC; Ehret JM
    Antimicrob Agents Chemother; 1976 Jun; 9(6):994-9. PubMed ID: 938029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro activity of cefoxitin, a new cephalosporin (author's transl)].
    Shah PM; Zwischenbrugger H; Stille W
    MMW Munch Med Wochenschr; 1976 Nov; 118(45):1469-72. PubMed ID: 825763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of BL-S786 with cephalothin, cefamandole and cefoxitin in vitro and in treatment of experimental infections in mice.
    Goering RV; Sanders CC; Sanders W
    J Antibiot (Tokyo); 1978 Apr; 31(4):363-72. PubMed ID: 306989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity of gentamicin-resistant Enterobacteriaceae to cefamandole and cefoxitin.
    Rosenthal SL; Freundlich LF; Quraishi MA
    Chemotherapy; 1979; 25(3):157-61. PubMed ID: 456076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the in vitro activities of HR756 with cephalothin, cefoxitin, and cefamandole.
    Sosna JP; Murray PR; Medoff G
    Antimicrob Agents Chemother; 1978 Dec; 14(6):876-9. PubMed ID: 742875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences between cephalothin and newer parenterally absorbed cephalosporins in vitro: a justification for separate disks.
    Washington JA II
    J Infect Dis; 1978 May; 137 Suppl():S32-S37. PubMed ID: 349096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paradoxical susceptibility to cephalothin and cefamandole of a Klebsiella pneumoniae isolate producing extended-spectrum beta-lactamase (TEM-3).
    Gaillot O; Mallea M; Philippon A; Pages JM; Simonet M
    J Antimicrob Chemother; 1996 Jan; 37(1):194-6. PubMed ID: 8647766
    [No Abstract]   [Full Text] [Related]  

  • 18. The in vitro spectrum of the cephalosporins.
    Washington JA
    Mayo Clin Proc; 1976 Apr; 51(4):237-50. PubMed ID: 1263595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysis if enterobacteria by cefoxitin, cefuroxime, and cephalothin.
    Goodwin CS; Hill JP
    Antimicrob Agents Chemother; 1977 Jan; 11(1):26-30. PubMed ID: 319751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between agar and broth minimum inhibitory concentrations of cefamandole, Cefoxitin, and cefuroxime.
    Rylander M; Brorson JE; Johnsson J; Norrby R
    Antimicrob Agents Chemother; 1979 Apr; 15(4):572-9. PubMed ID: 464588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.